Omeros
Open
$14.60
Prev. Close
$14.59
High
$14.60
Low
$14.58
Market Snapshot
$1.03B
-308.2
-2.71
175
The company is headquartered in Seattle, Washington and currently employs 202 full-time employees. The company went IPO on 2009-10-08.
emptyResult
The company is headquartered in Seattle, Washington and currently employs 202 full-time employees. The company went IPO on 2009-10-08.
Recently from Cashu
Update on Omeros: Recent Developments and Industry Insights
It appears that there is no specific content provided for me to summarize. If you could share the text or details about Omeros or relevant developments in the industry, I'd be glad to assist in creati…
Omeros Advances Therapeutics Amid Economic Uncertainty and Promotes Non-Opioid Pain Management
Omeros Advances in Therapeutic Development Amid Economic Uncertainty Omeros Corporation makes significant strides in the biopharmaceutical sector as it focuses on advancing its therapeutic pipeline. T…
Omeros Corporation Secures FDA Approval for Yartemlea to Treat TA-TMA
Omeros Corporation Gains FDA Approval for Yartemlea: A Breakthrough in Treating TA-TMA Omeros Corporation achieves a significant milestone with the U.S. Food and Drug Administration's (FDA) approval o…
Omeros Receives FDA Approval for Yartemlea to Treat TA-TMA in Stem Cell Transplants
Omeros Corporation Secures FDA Approval for Yartemlea in Treating TA-TMA Omeros Corporation achieves a significant milestone with the recent approval of Yartemlea (narsoplimab-wuug) by the U.S. Food a…